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Abstract Sphingosine 1-phosphate (S1P) induces phospholipase
C (PLC) activation and Ca2+ mobilization in many types of cells.
We examined the possible involvement of Edg-3, one of the
putative S1P receptors, in the phospholipase C (PLC)-Ca2+
system. S1P increased the cytoplasmic free Ca2+ concentration
without detectable inositol phosphate production in vector-
transfected CHO cells. In the Edg-3-transfected cells, however,
the S1P-induced Ca2+ response was clearly enhanced, which was
associated with a significant production of inositol phosphate.
These S1P-induced responses in the Edg-3-transfected cells were
inhibited by U73122, a potent PLC inhibitor. We conclude that
Edg-3 may be one of the S1P receptors participating in the
activation of the PLC-Ca2+ system.
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1. Introduction
Sphingosine 1-phosphate (S1P), one of the sphingolipid me-
tabolites, has recently been suggested to be involved in the
regulation of a variety of cellular processes [1,2]. There are
at least two mechanisms with respect to the action mode for
exogenous S1P, i.e. intracellular mechanisms through intra-
cellular targets molecules (which have not yet been identi¢ed)
and extracellular mechanisms through cell surface receptors
[1,2]. The presence of the latter mechanism has been sup-
ported by the recent identi¢cation of several cDNAs encoding
G-protein-coupled receptors for S1P, i.e. Edg-1, AGR16/H218
and Edg-3 [3^5].
As for the S1P-induced Ca2 mobilization, two action
mechanisms have also been reported. S1P was ¢rst reported
to directly act on the internal Ca2 pool resulting in Ca2
mobilization in a way similar to inositol 1,4,5-trisphosphate
in permeabilized cells or in the puri¢ed endoplasmic reticulum
[6^8]. S1P is accumulated in response to PDGF and serum in
Swiss 3T3 ¢broblasts; hence, this lipid has been proposed as a
second messenger of PDGF and serum during cell prolifera-
tion in Swiss 3T3 ¢broblasts [9]. A second messenger role of
S1P has also been suggested for the IgE receptor [10] and
some G-protein-coupled receptors [11]. In HL-60 cells, we
have shown that exogenous S1P also increased Ca2 but
this Ca2 increase was associated with phospholipase C
(PLC) activation [12]. These S1P-induced actions were mark-
edly suppressed by PTX, suggesting an involvement of PTX-
sensitive G-proteins in the lipid signaling. Furthermore, these
lipid actions were also inhibited by the dibutyryl cAMP-in-
duced di¡erentiation of the cells, in which the downstream
signaling pathway from the G-proteins was rather forti¢ed
[12,13]. This ruled out the possibility of G-proteins as the
action site of S1P, and hence we proposed that the S1P-in-
duced activation of the PLC-Ca2 system is mediated through
the G-protein-coupled receptors in HL-60 cells [12]. Partici-
pation of the G-proteins or cell surface receptors in the S1P-
induced Ca2 mobilization has also been suggested in other
cell types including ¢broblasts [14], HEK 293 [15], endothelial
cells [16], platelets [17], hepatocytes [18] and thyroid cells [19],
although the involvement of PLC has not always been dem-
onstrated for the [Ca2]i increase [14^16]. However, the recep-
tor subtype involved in activation of the PLC-Ca2 system
has not yet been identi¢ed.
We have recently found that only Edg-3 mRNA expression
was detected among the three putative lipid receptors in HL-
60 leukemia cells and this mRNA expression was markedly
attenuated in association with the inhibition of the S1P-in-
duced Ca2 response during di¡erentiation induced by several
agents including dibutyryl cAMP [20]. This raised the possi-
bility that Edg-3 might be a S1P receptor linking to the Ca2
signaling. To con¢rm this, in the present study, we transfected
Edg-3 cDNA into CHO cells which express AGR16/H218 but
do not express detectable amounts of Edg-3 and Edg-1
mRNAs [21]. The Edg-3-transfected CHO cells markedly ac-
tivated the PLC-Ca2 system in response to S1P. Thus, Edg-3
may be one of the S1P receptors involved in the activation of
the PLC-Ca2 system observed in many types of cells.
2. Materials and methods
2.1. Materials
1-Oleoyl-sn-glycero-3-phosphate (lysophosphatidic acid; LPA) and
D-erythro-sphingosine were purchased from Sigma; S1P from Cayman
Chemical Co.; sphingosylphosphorylcholine (SPC) from Biomol Re-
search Lab. Inc.; Fura 2/AM from Dojindo (Tokyo); and myo-
[2-3H]inositol (23.0 Ci/mmol) from DuPont-New England Nuclear.
U73122 and U73343 were generously provided by the Upjohn Co.
(Kalamazoo, MI). The sources of all other reagents were as previously
described [12,13,18,19].
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2.2. Cell cultures
Chinese hamster ovary (CHO) cells, which were transfected with the
pEFneo vector [22] (control cells) or pEFneoEdg-3 vector (Edg-3-
transfected cells), were cultured in DMEM containing 10% FBS on
10-cm dishes for Ca2 response and on 6-multiwell plates for inositol
phosphate response unless otherwise speci¢ed. Twenty-four hours be-
fore the experiments, the medium was changed to fresh DMEM (with-
out serum) containing 0.1% BSA. For the [Ca2]i measurement, the
cells were harvested and suspended cells were used. In the case of the
inositol phosphate response, the medium was changed to the inositol-
free DMEM containing 2 WCi [3H]inositol (in 1.5 ml) and 0.1% BSA.
After 24 h, inositol phosphate response was performed without cell
harvest. In the experiments shown in Fig. 4F, however, the cells were
labeled on 10-cm dishes in the inositol-free DMEM containing 20 WCi
[3H]inositol in 7 ml and the inositol phosphate response was per-
formed in a cell suspension as was case for the Ca2 response. PTX
treatment of the cells was performed by adding the toxin (50 ng/ml) to
the medium 24 h before the experiments.
2.3. Measurement of [3H]inositol phosphate production
In the case of the cells attached to the 6-multiwell plates, the
[3H]inositol-labeled cells were washed twice with HEPES-bu¡ered me-
dium which consisted of 20 mM HEPES (pH 7.5), 134 mM NaCl, 4.7
mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2, 2.5 mM
NaHCO3, 5 mM glucose, and 0.1% (w/v) bovine serum albumin (frac-
tion V), then preincubated with 0.9 ml of the same medium containing
10 mM LiCl. After 5 min, test agents (U10) in 0.1 ml were added to
the medium and further incubated for the indicated time. The reaction
was terminated by adding 1 N HCl (0.1 ml). The other procedures
were exactly the same as those previously described [12,23]. In the case
of the cell suspension (Fig. 4F, lower panel) where the e¡ects of
U73122, a PLC inhibitor, and U73343, an inactive derivative, were
examined, the [3H]inositol-labeled cells were harvested from the 10-cm
dishes with trypsin (0.05% in phosphate-bu¡ered saline containing
0.53 mM EDTA) and washed by sedimentation (250Ug, 5 min) and
resuspension with the HEPES-bu¡ered medium. The washing proce-
dure was repeated and the cells were ¢nally resuspended in the same
medium. The cells (about 3U106) were preincubated for 2 min with
5 WM U73122 or 5 WM U73343 in the presence of 10 mM LiCl in
polypropylene vials (20 ml) in a ¢nal volume of 2.0 ml. The test agents
(U100) were then added to the medium and the cells were further
incubated for 1 min. The cell suspension (0.5 ml) in triplicate was
transferred to tubes containing 1 ml of CHCl3/MeOH/HCl (100/100/
1). Where indicated, the results were normalized to 105 dpm of the
total radioactivity incorporated into the cellular inositol lipids. The
radioactivity of the trichloroacetic acid (5%)-insoluble fraction was
measured as the total radioactivity.
2.4. Measurement of [Ca2+]i
This was performed by the £uorescence change of Fura 2-loaded
cells. The cells were harvested from the dishes with trypsin as de-
scribed above. After the 20-min incubation of the cells with 1 mM
Fura 2/AM at 37‡C, the cells were washed two times with ice-cold
HEPES-bu¡ered medium and ¢nally suspended in the same medium.
The Fura 2-loaded cells were kept on ice while waiting for [Ca2]i
measurement. The cells were warmed at 37‡C for 1 min and then the
[Ca2]i change was monitored. If the cells were maintained at room
temperature, a higher response to test agents was usually observed
compared with the cells which were kept on ice, but we noticed that
the basal [Ca2]i sometimes increased spontaneously (net increase was
about 100 nM) then returned to the initial level (within about 3 min)
by stirring the cells, especially in the case of Edg-3-transfected cells.
When such a spontaneous [Ca2]i increase occurred, the Ca2 re-
sponse to test agents was markedly suppressed even when [Ca2]i
was measured after it returned to the initial level. Other experimental
conditions are the same as those previously described [23].
2.5. Isolation of cDNAs for S1P receptors and construction of
expression plasmid
The cDNA of Edg-3 [24] was cloned by RT-PCR from the total
RNA of HEK 293 cells with 5P-ggggaattcCCACCATGGCAACTG-
CCCTCCCGCCGCG-3P and 5P-gggtctagaTCAGTTGCAGAAGAT-
CCCATTCTG-3P. The 5P primers contain a restriction enzyme site
(EcoRI) and a Kozak sequence (CCACC) before the N-terminal re-
gion of the receptor proteins. The 3P primers contain a restriction
enzyme site (XbaI) and a stop codon in addition to the C-terminal
region of the receptor proteins. The ampli¢ed fragments were digested
with the restriction enzymes, put in the pBluescript II plasmids
(Stratagene) and the DNA sequence was checked.
To construct the Edg-3 expression plasmid, the ampli¢ed fragment
was inserted into the EcoRI/XbaI site of the pEFneo expression plas-
mid. Of the three types of the putative S1P receptors that have re-
cently been identi¢ed, the wild type CHO cells abundantly express the
mRNA of AGR16/H218 [25,26] at 3.1 kb, but not Edg-3 or Edg-1
(their expected size is 2.8 kb for Edg-3 [24] and 3.0 kb for Edg-1 [27]).
The CHO cells were transfected with pEFneo vector (control cells) or
pEFneo containing Edg-3 (Edg-3-transfected cells) and neomycin
(G418 sulfate)-resistant cells were selected. We prepared three sets
of transfected cells. These three sets of Edg-3-transfected cells all ex-
pressed an Edg-3 transcript around 1.8 kb, although we did not meas-
ured the expression of the S1P-receptor proteins. All the data pre-
sented in this study were from one set of transfected cells ; we
observed almost the same results using other sets of cells stably trans-
fected with Edg-3.
2.6. Data presentation
All experiments were performed in duplicate or triplicate. The re-
sults of multiple observations are presented as the representative or
means þ S.E.M. of at least three separate experiments unless otherwise
stated.
3. Results
Fig. 1 shows the e¡ects of S1P and UTP, a P2-purinergic
agonist, on the inositol phosphate production in the control
(pEFneo vector-transfected) CHO cells and Edg-3-transfected
cells. In the control cells (Fig. 1A^C), S1P failed to accumu-
late any inositol phosphate species. In the case of UTP, which
has been shown to activate PLC in many types of cells, we
only detected a signi¢cant accumulation of IP1, but not IP2 or
IP3. The presence of many species of IP2 and IP3 molecules
and their di¡erent metabolic rate might mask the signi¢cant
accumulation of these polyinositol phosphates. In the Edg-3-
transfected cells as well (Fig. 1D^F), UTP stimulated only IP1
accumulation to an extent similar to that in the control cells.
On the other hand, S1P signi¢cantly stimulated all the species
of inositol phosphates in the Edg-3-transfected cells. However,
the extent of the increase in rate of IP2 and IP3 production
(Fig. 1E,F) was less than that of IP1 production (Fig. 1D) at
all times employed in these cells, e.g. the percent increase over
basal at 1 min after S1P addition was 300% for IP1, 100% for
IP2 and only 20% for IP3.
The S1P-induced inositol phosphate production was parti-
ally suppressed by PTX treatment, whereas the toxin hardly
a¡ected the UTP-induced action; the toxin inhibited about
40% and 20% of the responses as induced by 10 nM S1P
and 1 mM S1P, respectively (Fig. 2). In CHO cells, LPA
can inhibit forskolin-induced cAMP accumulation in a
PTX-sensitive manner; cAMP accumulation (nmol/mg pro-
tein) induced by forskolin (10 WM) plus IBMX (0.5 mM) in
the absence and presence of LPA (10 WM) was 28.8 þ 0.8 and
20.9 þ 0.5 in the control cells non-treated with PTX and
29.4 þ 1.0 and 31.6 þ 0.8 in the toxin-treated cells, respectively,
in the case of Edg-3-transfected cells (n = 3). There was no
signi¢cant di¡erence in the LPA-induced e¡ect and the toxin
sensitivity between vector-transfected and Edg-3-transfected
cells (data not shown). Thus, PTX-sensitive G-proteins seem
to be almost completely inactivated by the toxin treatment
employed in the present study.
The dose-dependent e¡ect of S1P and its related com-
pounds on inositol phosphate production is shown in Fig. 3.
In vector-transfected cells, even 10 WM S1P was ine¡ective.
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Similarly, LPA (Fig. 3A), SPC and sphingosine (data not
shown) were ine¡ective for the induction of the inositol phos-
phate response. LPA was still ine¡ective in the Edg-3-trans-
fected cells, but both SPC and sphingosine at 10 WM exerted
signi¢cant e¡ects. Thus, SPC and sphingosine in addition to
S1P may interact with Edg-3 to activate PLC, although their
potency was about two orders less than that of S1P.
We ¢nally examined whether the inositol phosphate re-
sponse was actually accompanied by an increase in Ca2 re-
sponse. In vector-transfected cells, S1P slightly but signi¢-
cantly induced a transient [Ca2]i increase and this Ca2
response was completely inhibited by U73122, a PLC inhib-
itor (Fig. 4A,E), although S1P failed to increase inositol phos-
phate production in these cells (Figs. 1 and 3). The Ca2
response to S1P was clearly enhanced in the Edg-3-transfected
cells (Fig. 4B,D). The enhancement of the Ca2 response
was speci¢c to S1P; the LPA-induced action was unchanged
by the Edg-3 transfection (Fig. 4C,D). The S1P-induced
[Ca2]i increase in the Edg-3-transfected cells may also be
dependent on PLC activation based on the observation that
U73122, a potent PLC inhibitor, clearly inhibited the S1P-
induced increase in [Ca2]i (Fig. 4B,F) in association with
an inhibition of the lipid-induced inositol phosphate produc-
tion (Fig. 4F).
As expected from the PTX e¡ect on inositol phosphate
response to S1P in Edg-3-transfected cells (Fig. 2), the toxin
signi¢cantly inhibited the S1P-induced [Ca2]i increase (Fig.
4D). However, this does not simply mean the involvement of
PTX-sensitive G-proteins in the Edg-3-mediated [Ca2]i in-
crease, because the PTX-sensitive S1P-induced [Ca2]i in-
crease was also detected in the vector-transfected cells (Fig.
4C). To estimate the Edg-3-mediated response, we calculated
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Fig. 3. E¡ects of S1P and its related compounds on the inositol
phosphate production in the control vector-transfected cells (A) and
in the Edg-3-transfected cells (B). The [3H]inositol-labeled cells were
incubated for 10 min with the indicated doses of S1P (a), LPA
(O), SPC (b) or sphingosine (R). The production of total inositol
phosphates (IP1+IP2+IP3) was measured. Results are expressed as
percentages of the basal values obtained without the test agents.
Normalized basal values (dpm) were 4561 þ 59 and 4706 þ 74 in the
control cells and Edg-3-treated cells, respectively. Data are means
þ S.E.M. of three separate experiments.
Fig. 2. E¡ect of PTX on the inositol phosphate production induced
by S1P and UTP. The Edg-3-transfected cells labeled with
[3H]inositol were incubated for 10 min with the indicated doses of
S1P or UTP; cells non-treated with PTX (open column) and PTX-
treated cells (hatched column). Production of IP1 was measured, be-
cause the UTP e¡ect was only observed in this fraction (see Fig. 1).
Results are expressed as percentages over basal values obtained
without test agents. Normalized basal values were 1157 þ 54 for cells
non-treated with PTX and 1138 þ 77 for toxin-treated cells.
*P6 0.05, signi¢cant from control cells.
Fig. 1. E¡ects of S1P and UTP on the individual inositol phosphate
production in the control vector-transfected cells (left panels) and in
the Edg-3-transfected cells (right panels). The [3H]inositol-labeled
cells were incubated for the indicated time with bu¡er alone (a),
1 WM S1P (b) or 100 WM UTP (O). The production of IP1 (A,D),
IP2 (B,E) and IP3 (C,F) was measured. Results are expressed as per-
centages of the initial values before the addition of the test agents.
Normalized initial values (dpm) were 1313 þ 54 and 1180 þ 107 for
IP1, 1952 þ 108 and 1643 þ 96 for IP2 and 6085 þ 214 and 5780 þ 362
for IP3 in the control and Edg-3-treated cells, respectively. Data are
means þ S.E.M. of three separate experiments.
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the di¡erence in the respective values between the vector-
transfected cells and the Edg-3-transfected cells; these values
for non-treated cells and PTX-treated cells are 177 nM and 97
nM at 10 nM S1P and 252 nM and 179 nM at 1 WM S1P,
respectively. Thus, PTX treatment inhibited the Edg-3-medi-
ated Ca2 response about 45% at 10 nM S1P and 30% at 1 WM
S1P; these values are roughly comparable to the inhibition
rate of the Edg-3-mediated PLC activation by PTX (Fig. 2).
Thus, the S1P-induced [Ca2]i increase may be mediated
partly by PTX-sensitive G-proteins as was the case for the
lipid-induced PLC activation.
4. Discussion
Three types of cDNAs encoding G-protein-coupled recep-
tors for S1P, i.e. Edg-1, AGR16/H218 and Edg-3, have re-
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Fig. 4. E¡ect of Edg-3 transfection on S1P-induced [Ca2]i increase and a possible involvement of PLC activation in the Ca2 response. A,B:
Representative traces of [Ca2]i change by S1P in the control vector-transfected cells (A) and in the Edg-3-transfected cells (B) are shown. At
the arrow, S1P (WM), U73122 (5 WM), U73343 (5 WM), or its vehicle (DMSO) was added. C,D: E¡ects of PTX on the S1P- and LPA-induced
[Ca2]i increase in the control vector-transfected cells (C) and in the Edg-3-transfected cells (D) are shown. The cells non-treated with PTX
(open column) or PTX-treated cells (hatched column) were incubated with the indicated doses of S1P or LPA to monitor the [Ca2]i change.
The net [Ca2]i change (peak value minus basal value) at around 15 s is shown. Data are means þ S.E.M. of eight separate experiments. E¡ects
of PTX were signi¢cant in all cases. E,F: E¡ects of U73122 (hatched column) and U73343 (closed column) on S1P-induced [Ca2]i increase
and inositol phosphate production are shown. Inhibitor experiments on inositol phosphate response were performed only in Edg-3-transfected
cells, since a signi¢cant S1P e¡ect was not obtained in vector-transfected cells (see Fig. 1). Similar to the experiments shown in A and B, the
cells were ¢rst preincubated for 2 min with U73122 (5 WM), U73343 (5 WM) or their vehicle (DMSO) and then S1P (1 WM) was added to the
incubation medium. The net [Ca2]i changes induced by S1P in the control vector-transfected cells (E) and in the Edg-3-transfected cells (F,
upper panel) were measured and are expressed as percentages of values obtained in the control cells (DMSO) taken as 100%. The 100% value
was 74 þ 10 nM (E) and 348 þ 35 nM (F). In the lower panel of F, the [3H]inositol-labeled Edg-3-transfected cells were incubated for 1 min
with or without 1 WM S1P in the presence of the PLC inhibitor or its inactive derivative in the suspension similarly to the Ca2 response as de-
scribed in Section 2. The production of total inositol phosphates (IP1+IP2+IP3) was measured. The normalized value (dpm) was 1309 þ 36 with-
out S1P and 5006 þ 362 with S1P in the control cells (DMSO). Since the basal values without S1P were not signi¢cantly changed by the PLC
inhibitor and its inactive derivative, the results are expressed as percentages of the increments induced by S1P in the control cells (DMSO) tak-
en as 100%.
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cently been identi¢ed by several groups [3^5]. Edg-1 has been
suggested to couple to PTX-sensitive G-proteins to inhibit
adenylyl cyclase and ERK activation and couple to PTX-in-
sensitive G-proteins to modulate Rho-mediated changes in
morphology and motility [4,5,28]. However, its receptor sub-
type does not seem to be responsible for the Ca2 signaling
[4,5,28]. AGR16/H218 and Edg-3 have been shown to stimu-
late the Ca2 £ux in Xenopus oocytes [3]. However, the mech-
anism by which S1P stimulated the Ca2 e¥ux has not yet
been characterized. Furthermore, the observation in Xenopus
oocytes is not always reproducible in mammalian cell systems.
For example, an overexpression of a putative lysophosphati-
dic acid receptor, PSP24 [29], which was originally cloned
from Xenopus oocytes, enhanced the lipid-induced Ca2-medi-
ated Cl3 current in the same oocytes, but its action has not
yet been con¢rmed in mammalian cell systems. In the present
study, we stably transfected Edg-3 cDNA into CHO cells
which do not express detectable Edg-3 mRNA and demon-
strated that transfection of Edg-3 actually activated PLC in
response to S1P and enhanced the lipid-induced [Ca2]i in-
crease in the mammal cells.
The S1P-induced PLC activation may be responsible for the
lipid-induced [Ca2]i increase in the Edg-3-transfected cells as
evidenced from the inhibition of both responses to S1P by
U73122, a potent PLC inhibitor. The PTX treatment partially
inhibited S1P-induced PLC activation in association with the
parallel inhibition of the lipid-induced Ca2 response, further
suggesting the participation of PLC in the lipid-induced
[Ca2]i increase. The inhibition of the S1P-induced actions
by PTX also suggests the involvement of PTX-sensitive Gi/
Go proteins in lipid signaling. In the present study, although
we did not prove the complete ADP-ribosylation of Gi/Go
proteins by PTX, LPA-induced inhibition of cAMP accumu-
lation and increase in [Ca2]i were almost completely sup-
pressed by the toxin treatment, suggesting that the toxin treat-
ment under the present experimental conditions seems to
almost completely inactivate the function of Gi/Go proteins.
Taking it into consideration that Edg-3 is a G-protein-coupled
type of receptor, the PTX-insensitive S1P-induced PLC acti-
vation may be mediated through G11/Gq proteins. In relation
to the inhibitory action of LPA on adenylyl cyclase, we pre-
liminarily examined S1P e¡ects on cAMP accumulation. S1P
also slightly inhibited the forskolin-induced cAMP accumula-
tion in control CHO cells, but the inhibitory S1P action
disappeared in the Edg-3-transfected cells (data not shown).
The apparent reversal of the S1P action may be due to the
stimulatory action of S1P on cAMP accumulation in the
Edg-3-transfected cells. The detailed mechanism of action of
S1P on the regulation of cAMP metabolism is our current
subject of study. In any event, Edg-3 may couple to several
types of G-proteins, i.e. Gi/Go, G11/Gq and Gs proteins, re-
sulting in the stimulation of several intracellular signaling
pathways.
In the vector-transfected CHO cells as well, S1P signi¢-
cantly increased [Ca2]i. This may re£ect the abundant expres-
sion of AGR16/H218 in the control CHO cells [21]. As al-
ready mentioned, AGR16/H218 in addition to Edg-3 has been
suggested to stimulate Ca2 £ux at least in Xenopus oocytes
[3]. However, we could not detect any signi¢cant increase in
the production of inositol phosphates as a re£ection of the
PLC activation in response to S1P in the control (vector-
transfected) cells. The lack of signi¢cant production of inosi-
tol phosphate may simply re£ect the lower sensitivity for the
detection of the PLC assay compared with [Ca2]i measure-
ment, because the S1P-induced Ca2 response was lost in the
presence of a PLC inhibitor (Fig. 4A,E). Alternatively, it
might re£ect the di¡erence in the mechanism of Ca2 signal-
ing [11] between AGR16/H218 and Edg-3. This problem
should be clari¢ed in a future study.
In conclusion, Edg-3, which has been reported to be ex-
pressed in many types of tissues and organs including
heart, muscle and liver [20,24], may be one of the puta-
tive S1P receptors mediating the activation of the PLC-Ca2
system.
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